PapersFlow Research Brief
Blood disorders and treatments
Research Guide
What is Blood disorders and treatments?
Blood disorders and treatments is a research field examining the genetic basis, clinical features, and therapies for neutropenia disorders such as Shwachman-Diamond syndrome, Kostmann disease, and Cohen syndrome, driven by mutations in genes including ELANE, HAX1, GFI1, and SBDS that impair neutrophil development and function.
The field has produced 45,041 papers focused on genetic mutations and therapeutic interventions like hematopoietic stem cell transplantation and G-CSF therapy for neutropenia. Key studies detail molecular mechanisms in neutrophil function and extracellular traps (NETs). Research connects gene defects to disease manifestations and treatment responses.
Topic Hierarchy
Research Sub-Topics
ELANE Mutations in Neutropenia
This sub-topic covers pathogenic ELANE variants causing severe congenital and cyclic neutropenia phenotypes. Researchers characterize genotype-phenotype correlations, misfolding mechanisms, and therapeutic responses.
Shwachman-Diamond Syndrome
This sub-topic examines SBDS gene mutations, ribosomal dysfunction, and exocrine pancreatic insufficiency in Shwachman-Diamond syndrome. Researchers study leukemia predisposition, bone marrow failure progression, and HSCT outcomes.
G-CSF Therapy in Neutropenia
This sub-topic investigates granulocyte colony-stimulating factor pharmacokinetics, dosing optimization, and long-term safety in congenital neutropenias. Researchers monitor clonal evolution risks and response predictors.
HAX1 Deficiency
This sub-topic focuses on HAX1 mutations causing autosomal recessive severe congenital neutropenia and apoptosis defects. Researchers elucidate mitochondrial anti-apoptotic functions and ethnic prevalence patterns.
GFI1 in Neutropenia
This sub-topic covers GFI1 transcription factor mutations and zinc-finger variants disrupting granulopoiesis. Researchers analyze dominant-negative effects, gene dosage, and combined inheritance patterns.
Why It Matters
Treatments like azacitidine plus venetoclax extend overall survival in previously untreated acute myeloid leukemia patients ineligible for intensive chemotherapy, with higher remission rates than azacitidine alone, though febrile neutropenia incidence increases (DiNardo et al., 2020, "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia"). Bodey et al. (1966) established quantitative links between circulating leukocytes and infection risk in acute leukemia patients, informing clinical monitoring ("Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia"). Fuchs et al. (2010) showed neutrophil extracellular traps (NETs) promote thrombosis, revealing roles in clotting disorders ("Extracellular DNA traps promote thrombosis"). These findings guide therapies in hematology, reducing infection and complication risks in blood disorder patients.
Reading Guide
Where to Start
"Isolation of mononuclear cells and granulocytes from human blood" by Arne Bøyum (1968), as it provides foundational methods for studying neutrophils central to neutropenia research.
Key Papers Explained
Bøyum (1968) established cell isolation techniques in "Isolation of mononuclear cells and granulocytes from human blood," enabling leukocyte studies cited in Bodey et al. (1966) "Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia." Fuchs et al. (2010) "Extracellular DNA traps promote thrombosis" and Papayannopoulos et al. (2010) "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps" build on these by detailing NET mechanisms in thrombosis and immunity. DiNardo et al. (2020) "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia" applies insights to modern leukemia therapy.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research centers on genetic mutations in ELANE, HAX1, GFI1, and SBDS affecting neutrophil development, with focus on G-CSF therapy and stem cell transplantation efficacy, as no recent preprints or news are available.
Papers at a Glance
Frequently Asked Questions
What role do neutrophil extracellular traps play in thrombosis?
Neutrophil extracellular traps (NETs) consist of DNA fibers with histones and antimicrobial proteins that immobilize microbes but also promote thrombosis. Fuchs et al. (2010) demonstrated NETs trigger clot formation in "Extracellular DNA traps promote thrombosis". This mechanism links innate immunity to vascular complications in blood disorders.
How do neutrophil elastase and myeloperoxidase contribute to NET formation?
Neutrophil elastase (NE) and myeloperoxidase regulate NETosis by processing chromatin after reactive oxygen species activation. Papayannopoulos et al. (2010) showed NE decondenses chromatin in "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps". These enzymes are essential for extracellular pathogen trapping.
What is the effect of azacitidine and venetoclax in acute myeloid leukemia?
In patients ineligible for intensive chemotherapy, azacitidine plus venetoclax improves overall survival and remission rates over azacitidine alone. DiNardo et al. (2020) reported these outcomes in "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia". Febrile neutropenia occurs more frequently with the combination.
How are mononuclear cells and granulocytes isolated from human blood?
Arne Bøyum (1968) described isolating mononuclear cells by one centrifugation and granulocytes by combining centrifugation with sedimentation at 1 g in "Isolation of mononuclear cells and granulocytes from human blood". This method enables separation for neutropenia and leukemia studies. It supports research on neutrophil function.
What defines the relationship between leukocytes and infection in acute leukemia?
Lower circulating leukocyte counts correlate with higher infection risk in acute leukemia patients. Bodey et al. (1966) quantified this in "Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia". These data guide prophylactic measures.
What genetic factors underlie severe COVID-19 in blood disorder contexts?
Inborn errors of type I IFN immunity increase life-threatening COVID-19 susceptibility. Zhang et al. (2020) identified these in patients, linking to neutropenia-related immune defects in "Inborn errors of type I IFN immunity in patients with life-threatening COVID-19". Autoantibodies also dampen IFN responses.
Open Research Questions
- ? How do specific ELANE, HAX1, GFI1, and SBDS mutations differentially impair neutrophil maturation in Shwachman-Diamond syndrome versus Kostmann disease?
- ? What molecular pathways beyond reactive oxygen species control NET release in genetic neutropenias?
- ? Can G-CSF therapy combined with hematopoietic stem cell transplantation overcome SBDS gene defects in severe neutropenia?
- ? How do NETs interact with platelet TLR4 to exacerbate sepsis in congenital neutrophil disorders?
- ? What are the long-term outcomes of azacitidine-venetoclax in ELANE-mutated acute myeloid leukemia cases?
Recent Trends
The field encompasses 45,041 works on neutropenia genetics and treatments, with high-citation papers like DiNardo et al. "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia" (2552 citations) advancing leukemia care; growth rate over 5 years is not available, and no recent preprints or news reported.
2020Research Blood disorders and treatments with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Blood disorders and treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers